VETERINARY pharmaceutical company Parnell has established its North American headquarters in Overland Park, Kan.
The Australian company markets a number of products designed to improve reproductive management of dairy cattle.
According to the Agricultural Business Council of Kansas City, Mo., the company received a $400,000 grant from the Kansas Bioscience Authority in November to help relocate to the region's growing Animal Health Corridor. The new location will accommodate 13 employees in sales, marketing, finance, administration and clinical science, with plans to expand during the next few years.
"As we considered our entrance into the North American market, we felt it made total sense to locate our headquarters in the Animal Health Corridor in Kansas City," Parnell chief executive officer Robert Joseph said. "We look forward to the partnerships that we will be able to develop by being located here."
Established in Australia more than 50 years ago, Parnell launched estroPLAN (cloprostenol sodium) in the U.S. and Canada in 2009. The company has developed and launched more than 60 products for companion, production and performance animals.